• Department of Thoracic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, P.R.China;
WEI Yucheng, Email: weiyuchengchest@163.com
Export PDF Favorites Scan Get Citation

Surgery has remained the cornerstone of lung cancer therapy. Sleeve lobectomy, which is featured by not only the maximal resection of tumors but also the maximal preservation of functional lung parenchyma, has been proved to be a valid therapeutic option for the treatment of some centrally located lung cancer . Evidence points toward equivalent oncologic outcomes with improved survival and quality of life after sleeve resections compared with pneumonectomy. However, the postoperative morbidities and the long-term results after sleeve lobectomy remain controversial, especially in relation to nodal involvement and after induction therapy. With the development of technology, minimally invasive procedures have been performed more and more widely.

Citation: PAN Maojie, WEI Yucheng. Sleeve lobectomy for non-small cell lung cancer. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2018, 25(6): 526-532. doi: 10.7507/1007-4848.201711078 Copy

  • Previous Article

    Application of different molecular imaging techniques in predicting the progress of abdominal aortic aneurysm
  • Next Article

    胸骨下段小切口行非体外循环冠状动脉旁路移植术